GlassScriptPhysician profile
Adam Rozenstrauch
NPI 1689055519
$601.98
in general payments reported to CMS, 2019-2025
12 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.14 · 2022: $65.66 · 2023: $167 · 2024: $122 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $190.66 | 2023-2025 | Citrefix, Prophecy, Prostep Mica |
| Treace Medical Concepts, INC. | $84.36 | 2022-2024 | |
| Acumed LLC | $77.14 | 2021 | |
| Biowound Solutions, INC. | $76.64 | 2025 | Bio-Connekt |
| Next Science LLC | $34.60 | 2025 | Xperience, Blastx |
| Musculoskeletal Transplant Foundation INC. | $30.30 | 2024 | |
| Biotissue Holdings INC. | $22.11 | 2022 | |
| Convatec INC. | $21.64 | 2024 | |
| Orthofix Medical, INC. | $17.79 | 2025 | Physio-Stim |
| Acera Surgical, INC. | $17.68 | 2024 | Restrata Wound Matrix |
| Advanced Oxygen Therapy INC. | $17.00 | 2025 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Rozenstrauch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.